Literature DB >> 11781133

Adenosine receptors: G protein-mediated signalling and the role of accessory proteins.

Markus Klinger1, Michael Freissmuth, Christian Nanoff.   

Abstract

Ever since the discovery of the effects of adenosine in the circulation, adenosine receptors continue to represent a promising drug target. Firstly, this is due to the fact that the receptors are expressed in a large variety of cells; in particular, the actions of adenosine (or, respectively, of the antagonistic methylxanthines) in the central nervous system, in the circulation, on immune cells and on other tissues can be beneficial in certain disorders. Secondly, there exists a large number of ligands, which have been generated by introducing several modifications in the structure of the lead compounds (adenosine and methylxanthine), some of them highly specific. Four adenosine receptor subtypes have been identified by molecular cloning; they belong to the family of G protein-coupled receptors, which transfer signals by activating heterotrimeric G proteins. It has been appreciated recently that accessory proteins impinge on the receptor/G protein interaction and thus modulate the signalling reaction. These accessory components may be thought as adaptors that redirect the signalling pathway to elicit a cell-specific response. Here, we review the recent literature on adenosine receptors and place a focus on the role of accessory proteins in the organisation of adenosine receptor signalling. These components have been involved in receptor sorting, in the control of signal amplification and in the temporal regulation of receptor activity, while the existence of others is postulated on the basis of atypical cellular reactions elicited by receptor activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11781133     DOI: 10.1016/s0898-6568(01)00235-2

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  71 in total

1.  ATP-sensitive K(+) channels regulate the concentrative adenosine transporter CNT2 following activation by A(1) adenosine receptors.

Authors:  Sylvie Duflot; Bárbara Riera; Sonia Fernández-Veledo; Vicent Casadó; Robert I Norman; F Javier Casado; Carme Lluís; Rafael Franco; Marçal Pastor-Anglada
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

2.  Nucleoside triphosphate diphosphohydrolase-2 is the ecto-ATPase of type I cells in taste buds.

Authors:  Dianna L Bartel; Susan L Sullivan; Elise G Lavoie; Jean Sévigny; Thomas E Finger
Journal:  J Comp Neurol       Date:  2006-07-01       Impact factor: 3.215

Review 3.  The A(2A)-adenosine receptor: a GPCR with unique features?

Authors:  J Zezula; M Freissmuth
Journal:  Br J Pharmacol       Date:  2008-02-04       Impact factor: 8.739

Review 4.  Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation.

Authors:  Xiaolun Huang; Daniel J Moore; Robert J Ketchum; Craig S Nunemaker; Boris Kovatchev; Anthony L McCall; Kenneth L Brayman
Journal:  Endocr Rev       Date:  2008-07-29       Impact factor: 19.871

5.  Cardiac-restricted overexpression of the A(2A)-adenosine receptor in FVB mice transiently increases contractile performance and rescues the heart failure phenotype in mice overexpressing the A(1)-adenosine receptor.

Authors:  Tung O Chan; Hajime Funakoshi; Jianliang Song; Xue-Qian Zhang; JuFang Wang; Paul H Chung; Brent R DeGeorge; Xue Li; Jin Zhang; David E Herrmann; Maura Diamond; Eman Hamad; Steven R Houser; Walter J Koch; Joseph Y Cheung; Arthur M Feldman
Journal:  Clin Transl Sci       Date:  2008-09       Impact factor: 4.689

6.  Internalization and desensitization of adenosine receptors.

Authors:  Elisabeth C Klaasse; Adriaan P Ijzerman; Willem J de Grip; Margot W Beukers
Journal:  Purinergic Signal       Date:  2007-11-13       Impact factor: 3.765

7.  Reduced ability to release adenosine by diabetic rat cardiac fibroblasts due to altered expression of nucleoside transporters.

Authors:  Marzena Podgorska; Katarzyna Kocbuch; Marzena Grden; Andrzej Szutowicz; Tadeusz Pawelczyk
Journal:  J Physiol       Date:  2006-07-27       Impact factor: 5.182

8.  Synthesis and evaluation of N⁶-substituted apioadenosines as potential adenosine A₃ receptor modulators.

Authors:  Kiran S Toti; Steven M Moss; Silvia Paoletta; Zhan-Guo Gao; Kenneth A Jacobson; Serge Van Calenbergh
Journal:  Bioorg Med Chem       Date:  2014-05-23       Impact factor: 3.641

9.  Recent improvements in the development of A(2B) adenosine receptor agonists.

Authors:  Pier Giovanni Baraldi; Mojgan Aghazadeh Tabrizi; Francesca Fruttarolo; Romeo Romagnoli; Delia Preti
Journal:  Purinergic Signal       Date:  2009-01-31       Impact factor: 3.765

10.  Adenosine and stroke: maximizing the therapeutic potential of adenosine as a prophylactic and acute neuroprotectant.

Authors:  Rebecca L Williams-Karnesky; Mary P Stenzel-Poore
Journal:  Curr Neuropharmacol       Date:  2009-09       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.